Bio View Valuation
| BIOV Stock | ILS 26.20 0.90 3.56% |
At this time, the firm appears to be overvalued. Bio View shows a prevailing Real Value of S22.68 per share. The current price of the firm is S26.2. Our model approximates the value of Bio View from analyzing the firm fundamentals such as Profit Margin of 0.04 %, current valuation of 35.4 M, and Return On Equity of 0.0399 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bio View's price fluctuation is not too volatile at this time. Calculation of the real value of Bio View is based on 3 months time horizon. Increasing Bio View's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bio View is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio View's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.2 | Real 22.68 | Hype 26.2 | Naive 25.9 |
The real value of Bio Stock, also known as its intrinsic value, is the underlying worth of Bio View Company, which is reflected in its stock price. It is based on Bio View's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bio View's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bio View helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio View more accurately as focusing exclusively on Bio View's fundamentals will not take into account other important factors: Bio View Total Value Analysis
Bio View is currently forecasted to have takeover price of 35.4 M with market capitalization of 53.86 M, debt of 2.57 M, and cash on hands of 17.67 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bio View fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.4 M | 53.86 M | 2.57 M | 17.67 M |
Bio View Investor Information
About 52.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio View last dividend was issued on the 22nd of March 2017. The entity had 10:1 split on the 24th of December 2023. Based on the key measurements obtained from Bio View's financial statements, Bio View is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Bio View Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Bio suggests not a very effective usage of assets in November.Bio View Ownership Allocation
The market capitalization of Bio View is S53.86 Million. Bio View retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Bio View Profitability Analysis
The company reported the revenue of 30.51 M. Net Income was 2.18 M with profit before overhead, payroll, taxes, and interest of 17.59 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bio View's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bio View and how it compares across the competition.
About Bio View Valuation
The stock valuation mechanism determines Bio View's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bio View. We calculate exposure to Bio View's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bio View's related companies.BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Bio View's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bio View's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bio View's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bio View's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bio View's revenue streams: Identify Bio View's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bio View's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bio View's growth potential: Evaluate Bio View's management, business model, and growth potential.
- Determine Bio View's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bio View's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |